COVID-19 and Vision Damage: A Alarming Discovery by Managed Healthcare Executive

The Eye and COVID-19: What We Know From Recent Research

Introduction

The COVID-19 pandemic has affected millions of people worldwide and continues to present new challenges to public health. In this article, we will discuss recent research findings regarding COVID-19 and the eye, as well as other important topics related to eye health.

New Research on COVID-19 and the Eye

Recent research has revealed that COVID-19 can potentially damage the retina due to its ability to breach the blood-retinal barrier. This can cause long-term visual impairment and other serious complications. Researchers have found that the virus can infect not just the ocular surface, but also the retina itself. A study conducted with mice showed that even when the virus does not enter through the surface of the eyes, it can infect the retina through systemic exposure or inhalation. Furthermore, people who are immunocompromised or have underlying health conditions such as hypertension or diabetes are at greater risk of adverse ocular effects from COVID-19.

What This Means For Patients

If you have previously been diagnosed with COVID-19, it is essential to have your eyes checked by your ophthalmologist for any pathological changes that may be related to the virus. It is also important to note that even those who were asymptomatic can suffer damage to their eyes over time if left untreated. As COVID-19 research continues, patients should be mindful of the potential long-term effects of the virus on their eye health.

The Role of Omega-3 Fatty Acids in Eye Health

In recent years, there has been research conducted on the potential benefits of omega-3 fatty acids for eye health. However, a randomized clinical trial conducted in Korea found that one-gram capsules of omega-3 fatty acids did not reduce the risk of developing dry eye disease. This result contradicts previous studies that had suggested omega-3 fatty acid supplements could help treat dry eye disease. Therefore, further research is needed to determine the efficacy of these supplements for treating eye conditions.

Possible Benefits of Low-Dose Aspirin on AMD

Some large randomized trials have suggested that taking low doses of aspirin daily could be an easy, inexpensive way of lowering the risk of getting age-related macular degeneration. However, a well-designed, placebo-controlled study of septuagenarians conducted in Australia found no evidence to support this claim. Further research is necessary to determine the potential benefits of low-dose aspirin in preventing age-related macular degeneration.

C-Suite Positions in Healthcare

Briana Contreras, editor of Managed Healthcare Executive, interviewed Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Lurker discussed the innovative therapies that EyePoint Pharmaceuticals is utilizing and how they are addressing patient needs through eye care. Lurker also offered advice for those seeking C-Suite positions, particularly women in healthcare. According to Lurker, seeking out mentors and establishing a strong network of support are key factors in attaining a leadership role in healthcare.

Neighborhood Demographics and Vision Care

There is a significant mismatch between the demographics of the neighborhoods where Federally Qualified Health Centers (FQHCs) with vision care are located and those who are receiving vision services. This disparity highlights the importance of addressing access to vision care in underserved communities. Healthcare providers and policymakers must work together to ensure that everyone has access to essential eye care services.

Solar Eclipse and Eye Protection

Experts have warned that ordinary sunglasses may not be sufficient protection during a solar eclipse. It is crucial to wear eclipse glasses that are certified for safe viewing of the event. A pack of ten certified eclipse glasses is available for purchase on Amazon for $12.99, providing an affordable option for those looking to view the solar eclipse safely.

Originally Post From https://www.managedhealthcareexecutive.com/view/study-finds-covid-19-may-damage-vision